Evidence map›Paper›PMID 20361040›Full record

ArticlePLoS computational biology2010

Using pre-existing microarray datasets to increase experimental power: application to insulin resistance.

Bernie J Daigle, Alicia Deng, Tracey McLaughlin, Samuel W Cushman, Margaret C Cam, Gerald Reaven, Philip S Tsao, Russ B Altman

Open access · goldAbstract read
In one paragraph

Article in PLoS computational biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Imputing gene expression to maximize platform compatibility.Bioinformatics (Oxford, England) · 2017
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Bernie J DaigleDepartment of Genetics, Stanford University School of Medicine, Stanford, California, United States of America.
Alicia Deng
Tracey McLaughlin
Samuel W Cushman
Margaret C Cam
Gerald Reaven
Philip S Tsao
Russ B Altman
Stanford University · USNational Institute of Diabetes and Digestive and Kidney Diseases · USNational Institutes of Health · US

Funding

POSTDOCTORAL TRAINING IN MEDICAL INFORMATION SCIENCEST15LM007033 · NLM · STANFORD UNIVERSITY · PI SYLVIA KATINA PLEVRITIS · 1985 to 2026
$25.5M
PharmGKB: pharmacogenomics knowledge for precision medicineR24GM061374 · NIGMS · STANFORD UNIVERSITY · PI ALTMAN, RUSS BIAGIO, KLEIN, TERI ELLEN · 2010 to 2018
$25.2M
THE STANFORD PHARMACOGENETICS KNOWLEDGE BASEU01GM061374 · NIGMS · STANFORD UNIVERSITY · PI ALTMAN, RUSS BIAGIO · 2000 to 2009
$24.0M
Integrating the Metabolic and Genetic Faces of ObesityR01DK071309 · NIDDK · STANFORD UNIVERSITY · PI REAVEN, GERALD M. · 2005 to 2008
$1.3M
Heterogeneity of Fat Depots: Biological Differences Related to Insulin ResistanceR01DK080436 · NIDDK · STANFORD UNIVERSITY · PI MCLAUGHLIN, TRACEY · 2009 to 2011
$1.1M
Adipogenesis and Insulin ResistanceZIADK075014 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI CUSHMAN, SAMUEL · 2009 to 2013
$1.1M
Integrating the Metabolic and Genetic Faces of ObesityR01DK071333 · NIDDK · STANFORD UNIVERSITY · PI TSAO, PHILIP S · 2005 to 2008
$902k
Howard Hughes Medical InstituteNIDDK NIH HHS DK071309NIDDK NIH HHS DK071333NIDDK NIH HHS R01 DK071309NIDDK NIH HHS R01 DK071333NIDDK NIH HHS R01 DK080436NIGMS NIH HHS GM61374NIGMS NIH HHS R24 GM061374NIGMS NIH HHS U01 GM061374NLM NIH HHS T15 LM007033
6 · The paper itself

Abstract

Although they have become a widely used experimental technique for identifying differentially expressed (DE) genes, DNA microarrays are notorious for generating noisy data. A common strategy for mitigating the effects of noise is to perform many experimental replicates. This approach is often costly and sometimes impossible given limited resources; thus, analytical methods are needed which increase accuracy at no additional cost. One inexpensive source of microarray replicates comes from prior work: to date, data from hundreds of thousands of microarray experiments are in the public domain. Although these data assay a wide range of conditions, they cannot be used directly to inform any particular experiment and are thus ignored by most DE gene methods. We present the SVD Augmented Gene expression Analysis Tool (SAGAT), a mathematically principled, data-driven approach for identifying DE genes. SAGAT increases the power of a microarray experiment by using observed coexpression relationships from publicly available microarray datasets to reduce uncertainty in individual genes' expression measurements. We tested the method on three well-replicated human microarray datasets and demonstrate that use of SAGAT increased effective sample sizes by as many as 2.72 arrays. We applied SAGAT to unpublished data from a microarray study investigating transcriptional responses to insulin resistance, resulting in a 50% increase in the number of significant genes detected. We evaluated 11 (58%) of these genes experimentally using qPCR, confirming the directions of expression change for all 11 and statistical significance for three. Use of SAGAT revealed coherent biological changes in three pathways: inflammation, differentiation, and fatty acid synthesis, furthering our molecular understanding of a type 2 diabetes risk factor. We envision SAGAT as a means to maximize the potential for biological discovery from subtle transcriptional responses, and we provide it as a freely available software package that is immediately applicable to any human microarray study.

Indexed as

AlgorithmsDatabases, ProteinArtificial IntelligenceGene Expression ProfilingInformation Storage and RetrievalInsulin ResistanceOligonucleotide Array Sequence AnalysisPattern Recognition, AutomatedProteomeProteome

Identifiers

PMID20361040
PMCPMC2845644
OpenAlexW2079105976

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.